Additional file 2 of Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

Additional file 2: Table S1. List of NSCLC data sets analyzed. Table S2. ICR classification and correlation with clinico-pathological and biological variables in the 162 NSCLC samples. Table S3. ICR classification and correlations with biological variables in the 556 TCGA NSCLC samples. Table S4. Normalized gene expression data for the 44 NSCLC samples included in the study.

附加文件2：表S1。本研究分析的非小细胞肺癌（Non-Small Cell Lung Cancer, NSCLC）数据集列表。表S2：162例NSCLC样本中的ICR分类及其与临床病理、生物学变量的相关性。表S3：556例癌症基因组图谱（The Cancer Genome Atlas, TCGA）来源的NSCLC样本中的ICR分类及其与生物学变量的相关性。表S4：本研究纳入的44例NSCLC样本的标准化基因表达数据。